FR11C0033I1 - - Google Patents

Info

Publication number
FR11C0033I1
FR11C0033I1 FR11C0033C FR11C0033I1 FR 11C0033 I1 FR11C0033 I1 FR 11C0033I1 FR 11C0033 C FR11C0033 C FR 11C0033C FR 11C0033 I1 FR11C0033 I1 FR 11C0033I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR11C0033I1 publication Critical patent/FR11C0033I1/fr
Application granted granted Critical
Publication of FR11C0033I2 publication Critical patent/FR11C0033I2/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
FR11C0033C 1997-03-27 2011-08-18 CORRECTION OF DUPUYTREN’S CONTRACTURE Active FR11C0033I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/826,015 US6086872A (en) 1997-03-27 1997-03-27 Amelioration of dupuytren's disease
FR9803320A FR2772273B1 (en) 1997-03-27 1998-03-18 CORRECTION OF DUPUYTREN CONTRACT

Publications (2)

Publication Number Publication Date
FR11C0033I1 true FR11C0033I1 (en) 2011-09-23
FR11C0033I2 FR11C0033I2 (en) 2012-03-16

Family

ID=25245473

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9803320A Expired - Lifetime FR2772273B1 (en) 1997-03-27 1998-03-18 CORRECTION OF DUPUYTREN CONTRACT
FR11C0033C Active FR11C0033I2 (en) 1997-03-27 2011-08-18 CORRECTION OF DUPUYTREN’S CONTRACTURE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9803320A Expired - Lifetime FR2772273B1 (en) 1997-03-27 1998-03-18 CORRECTION OF DUPUYTREN CONTRACT

Country Status (8)

Country Link
US (2) US6086872A (en)
AU (1) AU733208B2 (en)
DE (1) DE19813748A1 (en)
DK (1) DK177324B1 (en)
FR (2) FR2772273B1 (en)
GB (1) GB2323530B (en)
NO (1) NO981388L (en)
SE (1) SE522723C2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
ES2548516T3 (en) 2005-01-21 2015-10-19 The Research Foundation Of The State University Of New York Methods for the treatment of adhesive capsulitis
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
ITPD20050207A1 (en) * 2005-07-07 2007-01-08 Fidia Farmaceutici NEW PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACID AND COLLAGENAS IN THE TOPIC TREATMENT OF WOUNDS, BURNS AND ULCERS
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2008100833A2 (en) * 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (en) 2008-03-06 2013-05-11 Halozyme Inc In vivo temporal control of activatable matrix-degrading enzymes
JP5649589B2 (en) 2009-03-06 2015-01-07 ハロザイム インコーポレイテッド Temperature-sensitive mutant of matrix metalloproteinase 1 and use thereof
WO2010111525A2 (en) 2009-03-25 2010-09-30 Agee, John, M., Trustee Of The John M. Agee Trust Of August 15, 1996 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
EP2632446B1 (en) 2010-10-30 2018-12-12 Oxford University Innovation Limited Treatment for dupuytren's disease
WO2012125948A1 (en) 2011-03-16 2012-09-20 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
AU2012285378B2 (en) 2011-07-20 2017-03-02 Mediwound Ltd. Proteolytic extract from bromelain for the treatment of connective tissue disorders
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
EP3584317B1 (en) 2012-01-12 2021-11-24 Endo Global Ventures Clostridium histolyticum enzyme
US20150079069A1 (en) * 2012-04-30 2015-03-19 Elastomics Ab Methods for modification of tissues
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
JP2016515521A (en) 2013-03-15 2016-05-30 バイオスペシフィクス テクノロジーズ コーポレーション Method and product for treatment of uterine fibroids using purified collagenase
CN103751102A (en) 2014-01-15 2014-04-30 上海交通大学 Collagenase thermoresponsive hydrogel and preparation method and application of hydrogel
CN115969318A (en) 2017-03-01 2023-04-18 恩多风投有限公司 Device and method for evaluating and treating cellulite
MX2019011574A (en) 2017-03-28 2019-12-19 Endo Ventures Ltd Improved method of producing collagenase.
EP4045078A1 (en) 2019-10-15 2022-08-24 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase

Also Published As

Publication number Publication date
SE522723C2 (en) 2004-03-02
GB9805050D0 (en) 1998-05-06
AU5966198A (en) 1998-10-01
FR2772273A1 (en) 1999-06-18
NO981388D0 (en) 1998-03-26
FR2772273B1 (en) 2003-04-25
NO981388L (en) 1998-09-28
SE9800806L (en) 1998-09-28
DK177324B1 (en) 2013-01-07
GB2323530A (en) 1998-09-30
GB2323530B (en) 2001-10-10
AU733208B2 (en) 2001-05-10
USRE39941E1 (en) 2007-12-18
DK40398A (en) 1998-09-28
SE9800806D0 (en) 1998-03-12
FR11C0033I2 (en) 2012-03-16
DE19813748A1 (en) 1998-10-01
US6086872A (en) 2000-07-11

Similar Documents

Publication Publication Date Title
FR07C0057I1 (en)
JP2001512066A5 (en)
FR11C0033I1 (en)
IN188155B (en)
IN1998DE02392A (en)
ITMI970956A0 (en)
ITMI970342V0 (en)
ITMI971065A0 (en)
ITFI970042V0 (en)
IN192305B (en)
ITMI971048A0 (en)
IN186653B (en)
ITRM970132V0 (en)
CN3058162S (en)
CN3057614S (en)
CN3059396S (en)
CN3059079S (en)
CN3059024S (en)
CN3058984S (en)
CN3058923S (en)
CN3058533S (en)
CN3058531S (en)
CN3058462S (en)
CN3058320S (en)
CN3055603S (en)